13. References
[1] M. del Campo et al. ( 2012). Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update. Biomark. Med 6;4:419-30.
[2] K. Blennow et al. (2010). Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Reviews Neurology 6: 131-144
[3] M. Anderssen et al. (2012). The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia. International Journal of Geriatric Psychiatry
26; 1:100-105
[4] A. Wimo et al. ( 2003). The magnitude of dementia occurrence in the world. Alzheimer’s Dis. Assoc Disord. 17; 2:63-7.
[5] C.R. Jack et al (2011). Introduction to the recommendation from the National Institute on Aging Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia 7; 3:257-62.
[6] R. Peterson et al. (2004). Mild cognitive impairment as a diagnostic entity. Jr Int Med. 256:183-194.
[7] K. Schmidtke et al. (2008). High rate of conversion to Alzheimer’s Disease in a cohort of amnestic MCI patients.20:96–108.
[8] L. M. Shaw et al. (2009). Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann Neurol 65; 4:403-13
[9] M. Pesaresi et al. (2006). Plasma levels of beta- amyloid (1-42) in Alzheimer’s disease and mild cognitive impairment. Neurobiol of Aging 27: 904-905.
[10] A. Hye et al (2007). Proteomics of Alzheimer’s disease: understanding mechanism and seeking biomarkers. JAMA 4; 2:227-238.
[11] H. Hampel et al (2011). Biomarkers for Alzheimer’s disease therapeutic trials. Prog Neurobiol 95;4:579-593.
[12] G. McKhann et al (1984) . Clinical diagnosis of Alzheimer’s disease: report of the NINCDS_ ADRDA Work Group under the auspices of Department of Health and Human Services Tack Force on Alzheimer’s Disease. Neurology 34; 7:939-44.
[13] B. Winblad et al (2004). Mild Cognitive Impairment- beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Jr Intern Med 256: 240–246.